INCORPORATION OF THE CATALYTIC DOMAIN OF A HAMMERHEAD RIBOZYME INTO ANTISENSE RNA ENHANCES ITS INHIBITORY EFFECT ON THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
M. Homann et al., INCORPORATION OF THE CATALYTIC DOMAIN OF A HAMMERHEAD RIBOZYME INTO ANTISENSE RNA ENHANCES ITS INHIBITORY EFFECT ON THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Nucleic acids research, 21(12), 1993, pp. 2809-2814
The catalytic domain of a hammerhead ribozyme was incorporated into a
413 nucleotides long antisense RNA directed against the 5'-leader/gag
region of the human immunodeficiency virus type 1 (HIV-1) (pos. + 222
to + 634). The resulting catalytic antisense RNA was shown to cleave i
ts target RNA in vitro specifically at physiological ion strength and
temperature. We compared the antiviral effectiveness of this catalytic
antisense RNA with that of the corresponding unmodified antisense RNA
and with a mutated catalytic antisense RNA, which did not cleave the
substrate RNA in vitro. Each of these RNAs was co-transfected into hum
an SW480 cells together with infectious complete proviral HIV-1 DNA, f
ollowed by analysis of HIV-1 replication. The presence of the catalyti
cally active domain resulted in 4 to 7 fold stronger inhibition of HIV
-1 replication as compared to the parental antisense RNA and the inact
ive mutant. Kinetic and structural studies performed in vitro indicate
d that the ability for double strand formation was not changed in cata
lytic antisense RNA versus parental antisense RNA. Together, these dat
a suggest that the ability to cleave target RNA is a crucial prerequis
ite for the observed increase of inhibition of the replication of HIV-
1.